$NVCT
Nuvectis Pharma, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$22.00
▲+2.90%+$0.620
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateNuvectis Pharma, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is NVCT up today? It is at $22.00 (+2.90%), and our scanner flagged it 24 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment NVCT spikes, and full due diligence on NVCT — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $NVCT 24 times in the last 30 days. Create a free account to track $NVCT, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on NVCT from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for NVCT today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
From the trading subreddits (WallStreetBets, r/stocks and more). Retail chatter, not a signal. Do your own research.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Carson Michael J. Officer | Acquired (grant/award) | +30K 0.09% of company | added 15% | 230K | n/a | Aug 3, 26 |
Bentsur Ron Officer | Bought (open market) | +13K 0.04% of company | added 0.3% | 3.69M | $250K at $20.00 | Jun 30, 26 |
Mosseri Marlio Charles Beneficial Owner (10%) | Bought (open market) | +50K 0.2% of company | added 1.6% | 3.19M | $916K at $18.32 | Jun 30, 26 |
Kaplan Matthew L. Director | Acquired (grant/award) | +35K 0.1% of company | added 28% | 160K | n/a | Jun 11, 26 |
Sanchez Juan Director | Acquired (grant/award) | +35K 0.1% of company | added 45% | 113K | n/a | Jun 11, 26 |
Oliviero James F Iii Director | Acquired (grant/award) | +35K 0.1% of company | added 40% | 123K | n/a | Jun 11, 26 |
Hoberman Kenneth Director | Acquired (grant/award) | +35K 0.1% of company | added 26% | 168K | n/a | Jun 11, 26 |
Carson Michael J. Officer | Acquired (grant/award) | +61K 0.2% of company | added 44% | 200K | n/a | Jan 6, 26 |
Poradosu Enrique Officer | Acquired (grant/award) | +150K 0.5% of company | added 9.1% | 1.81M | n/a | Jan 6, 26 |
Bentsur Ron Officer | Acquired (grant/award) | +150K 0.5% of company | added 4.3% | 3.68M | n/a | Jan 6, 26 |
Shemesh Shay Officer | Acquired (grant/award) | +150K 0.5% of company | added 9.1% | 1.79M | n/a | Jan 6, 26 |
Kaplan Matthew L. Director | Bought (open market) | +11K 0.03% of company | added 9.7% | 125K | $64K at $5.84 | Nov 5, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on NVCT from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for NVCT today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
NVCT last traded at $22.00, up 2.90% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Nuvectis Pharma, Inc. Common Stock (NVCT) is next expected to report earnings on Tuesday, November 3, 2026, about 44 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The NVCT Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged NVCT 24 times in the last 30 days.
NVCT (Nuvectis Pharma, Inc. Common Stock) trades on XNAS, with a market cap of about $717M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge NVCT for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$NVCT discussion
Sign in to ask a question or join the discussion.